1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Intravenous Immunoglobulin Market – By Type

1.3.2        MEA Intravenous Immunoglobulin Market – By Application

1.3.3        MEA Intravenous Immunoglobulin Market – By Distribution Channel

1.3.4        MEA Intravenous Immunoglobulin Market – By End User

1.3.5        MEA Intravenous Immunoglobulin Market – By Country

2.           MEA Intravenous Immunoglobulin Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Intravenous Immunoglobulin Market – Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Expert Opinion

5.           MEA Intravenous Immunoglobulin Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Immunodeficiency Diseases

5.1.2        Increasing Geriatric Population

5.2         Market Restraints

5.2.1        Adverse Effects of Immunoglobulin Therapy

5.3         Future Trends

5.3.1        Strong Pipeline Candidates for IVIG

5.4         Impact Analysis

6.           Intravenous Immunoglobulin Market– MEA Analysis

6.1         MEA Intravenous Immunoglobulin Market Revenue Forecast and Analysis

7.           MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028– by Type

7.1         Overview

7.2         MEA Intravenous Immunoglobulin Market, By Type 2022 & 2028 (%)

7.3         IgG

7.3.1        Overview

7.3.2        IgG Revenue and Forecast to 2028 (US$ Million)

7.4         IgM

7.4.1        Overview

7.4.2        IgM - Revenue and Forecast to 2028 (US$ Million)

7.5         IgA

7.5.1        Overview

7.5.2        IgA - Revenue and Forecast to 2028 (US$ Million)

7.6         IgE

7.6.1        Overview

7.6.2        IgE - Revenue and Forecast to 2028 (US$ Million)

7.7         IgD

7.7.1        Overview

7.7.2        IgD - Revenue and Forecast to 2028 (US$ Million)

8.           MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by Application

8.1         Overview

8.2         MEA Intravenous Immunoglobulin Market, By Application 2022 & 2028 (%)

8.3         Hypogammaglobulinemia

8.3.1        Overview

8.3.2        Hypogammaglobulinemia - Market Revenue and Forecast to 2028 (US$ Million)

8.4         Chronic Inflammatory Demyelinating Polyneuropathy

8.4.1        Overview

8.4.2        Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Immunodeficiency Diseases

8.5.1        Overview

8.5.2        Immunodeficiency Diseases - Market Revenue and Forecast to 2028 (US$ Million)

8.6         Myasthenia Gravis

8.6.1        Overview

8.6.2        Myasthenia Gravis - Market Revenue and Forecast to 2028 (US$ Million)

8.7         Multifocal Motor Neuropathy

8.7.1        Overview

8.7.2        Multifocal Motor Neuropathy - Market Revenue and Forecast to 2028 (US$ Million)

8.8         Idiopathic Thrombocytopenic Purpura

8.8.1        Overview

8.8.2        Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecast to 2028 (US$ Million)

8.9         Inflammatory Myopathies

8.9.1        Overview

8.9.2        Inflammatory Myopathies - Market Revenue and Forecast to 2028 (US$ Million)

8.10      Specific Antibody Deficiency

8.10.1     Overview

8.10.2     Specific Antibody Deficiency - Market Revenue and Forecast to 2028 (US$ Million)

8.11      Guillain-Barre Syndrome

8.11.1     Overview

8.11.2     Guillain-Barre Syndrome - Market Revenue and Forecast to 2028 (US$ Million)

8.12      Others

8.12.1     Overview

8.12.2     Others - Market Revenue and Forecast to 2028 (US$ Million)

9.           MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by Distribution Channel

9.1         Overview

9.2         MEA Intravenous Immunoglobulin Market, By Distribution Channel 2022 & 2028 (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others - Market Revenue and Forecast to 2028 (US$ Million)

10.        MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by End User

10.1      Overview

10.2      MEA Intravenous Immunoglobulin Market, By End User 2022 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)

10.4      Specialty Clinics

10.4.1     Overview

10.4.2     Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)

10.5      Others

10.5.1     Overview

10.5.2     Others - Market Revenue And Forecasts To 2028 (US$ Million)

11.        MEA Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Overview

11.1.1     Middle East & Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Country (%)

11.1.1.1       Saudi Arabia: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1       Overview

11.1.1.1.2       Saudi Arabia Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3       Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)

11.1.1.1.4       Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)

11.1.1.1.5       Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)

11.1.1.1.6       Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)

11.1.1.2       South Africa: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1       Overview

11.1.1.2.2       South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3       South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)

11.1.1.2.4       South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)

11.1.1.2.5       South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)

11.1.1.2.6       South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)

11.1.1.3       UAE: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1       Overview

11.1.1.3.2       UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3       UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)

11.1.1.3.4       UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)

11.1.1.3.5       UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)

11.1.1.3.6       UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)

11.1.1.4       Rest of the Middle East and Africa: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.4.1       Overview

11.1.1.4.2       Rest of the Middle East and Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.3       Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)

11.1.1.4.4       Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)

11.1.1.4.5       Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)

11.1.1.4.6       Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)

12.        MEA Intravenous Immunoglobulin Market–Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Takeda Pharmaceutical Company Limited

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Grifols, S.A.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADMA Biologics, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bio Products Laboratory Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Shanghai RAAS

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Octapharma AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Kedrion S.p.A

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      CSL Behring (CSL Limited)

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Prothya Biosolutions B.V.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms in Intravenous Immunoglobulin Market

LIST OF TABLES

Table 1.             MEA Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)

Table 3.             Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 4.             Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)

Table 5.             Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 6.             South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)

Table 7.             South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 8.             South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)

Table 9.             South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 10.          UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)

Table 11.          UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 12.          UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)

Table 13.          UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 14.          Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)

Table 15.          Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 16.          Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)

Table 17.          Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 18.          Recent Inorganic Growth Strategies in the Intravenous Immunoglobulin Market

Table 19.          Recent Organic Growth Strategies in the Intravenous Immunoglobulin Market

Table 20.          Glossary of Terms in Intravenous Immunoglobulin Market

LIST OF FIGURES

Figure 1.           MEA Intravenous Immunoglobulin Market Segmentation

Figure 2.           MEA Intravenous Immunoglobulin Market Segmentation, By Country

Figure 3.           MEA Intravenous Immunoglobulin Market Overview

Figure 4.           MEA Intravenous Immunoglobulin Market, by Type

Figure 5.           MEA Intravenous Immunoglobulin Market, by Country

Figure 6.           Middle East & Africa: PEST Analysis

Figure 7.           Impact Analysis

Figure 8.           MEA Intravenous Immunoglobulin Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           MEA Intravenous Immunoglobulin Market, by Type 2022 & 2028 (%)

Figure 10.        MEA IgG Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        MEA IgM - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        MEA IgA - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        MEA IgE - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        MEA IgD - Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        MEA Intravenous Immunoglobulin Market, by Application 2022 & 2028 (%)

Figure 16.        MEA Hypogammaglobulinemia - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        MEA Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        MEA Immunodeficiency Diseases - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        MEA Myasthenia Gravis - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        MEA Multifocal Motor Neuropathy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        MEA Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        MEA Inflammatory Myopathies - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        MEA Specific Antibody Deficiency - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        MEA Guillain-Barre Syndrome - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        MEA Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        MEA Intravenous Immunoglobulin Market, by Distribution Channel 2022 & 2028 (%)

Figure 27.        MEA Hospital Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        MEA Retail Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        MEA Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        MEA Intravenous Immunoglobulin Market, by End User 2022 & 2028 (%)

Figure 31.        MEA Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 32.        MEA Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 33.        MEA Others- Market Revenue And Forecasts To 2028 (US$ Million)

Figure 34.        Middle East & Africa Intravenous Immunoglobulin Market Revenue Overview, by Country, 2022 (US$ Million)

Figure 35.        Middle East & Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Country (%)

Figure 36.        Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 37.        South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 38.        UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 39.          Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)